Have a personal or library account? Click to login
The Effect of Arterial PaCO2 in COPD Exacerbations with and without Peripheral Edema Cover

The Effect of Arterial PaCO2 in COPD Exacerbations with and without Peripheral Edema

Open Access
|Dec 2015

References

  1. 1. JONES W, BRUSSELLE G, DAL NEGRO RW, FERRER M, KARDOS P, LEVY ML et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respiratory Medicine 2011; 105(1):57-66.10.1016/j.rmed.2010.09.004
  2. 2. ALFONSO A, VERHAMME K, STURKENBOOM M, BRUSSELLE G. COPD in the general population: Prevalence, incidence and survival. Respiratory Medicine, 2011; 105(12):1872-1884.10.1016/j.rmed.2011.06.012
  3. 3. YAZDANPANAH L, SHIDFAR F, MOOSAVI A.J, HEIDARNAZHAD H, HAGHANI H. Energy and protein intake and its relationship with pulmonary function in chronic obstructive pulmonary disease (COPD) patients. Acta Medica Iranica 2010; 48(6): 374.
  4. 4. RAND SUTHERLAND E, CHERNIACK M. Management of chronic obstructive pulmonary disease. New Eng J Med 2004; 350: 2689-97.10.1056/NEJMra030415
  5. 5. MOBERG M, VESTBO J, MARTINEZ G, LANGE P, RINGBAEK T. Prognostic value of C-Reactive protein, leukocytes, and vitamin D in severe chronic obstructive pulmonary disease of outcome in COPD. Scientific World Journal 2014; 2014: 140736.10.1155/2014/140736
  6. 6. GULL MR, GEJUDO P, RODRIGUEZ-TRIGO G, GALDIZ JB, CAZOLIVE V, REGUEIRO M et al. Standards of quality care in respiratory rehabilitation in patients with chronic pulmonary disease. Arch Bronchopneumol 2012; 48:369-404.10.1016/j.arbr.2012.08.003
  7. 7. VIJAYAN VK. Chronic obstructive pulmonary disease. Indian J Med Res 2013; 137(2):251-69.
  8. 8. HAN MK, MCLAUGHLIN VV, CRINER GJ, MARTINEZ FJ. Pulmonary diseases and the heart. Circulation 2007; 116 (25): 2992-3005.10.1161/CIRCULATIONAHA.106.685206
  9. 9. HEMLIN M, LJUNGMAN S, CARLSON J, MALJUKANIC S, MOBINI R, BECH-HANSSEN O et al. The effects of hypoxemia and hypercapnia on renal and heart function hemodynamics and plasma hormone levels in stable COPD patients. Clin Respir J 2007; 1(2):80-90.10.1111/j.1752-699X.2007.00031.x
  10. 10. PIKE D, PARRAGA G. Chronic obstructive pulmonary disease. More imaging, more phenotyping, better care? Can Respir J 2013; 20(2):90.
  11. 11. HILDE JM1, SKJØRTEN I, GRØTTA OJ, HANSTEEN V, MELSOM MN, HISDAL J et al. Right venticular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension. J Am Coll Cardiol 2013; 62(12):1103-11.10.1016/j.jacc.2013.04.091
  12. 12. DEKHUIJZEN PN, BROEDERS ME, TUUT MK, GROL MH. Medical treatment of COPD. Ned Tijdschr Geneeskd 2008 28; 152(26):1465-8.
  13. 13. WEITZENBLUM E, APPRILL M, OSWALD M, CHAOUAT A, IMBS JL. Pulmonary hemodynamics in patients with chronic obstructive pulmonary disease before and during an episode of peripheral edema. Chest 1994; 105(5): 1377-82.10.1378/chest.105.5.1377
  14. 14. HODGKIN JE. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med 1990; 11 (3): 550-69.10.1016/S0272-5231(21)00717-6
  15. 15. ELÇI A, BÖREKÇI S, OVAYOLU N, ELBEK O. The efficacy and applicability of a pulmonary rehabilitation programme for patients with COPD in a secondary – care community hospital. Respir 2008; 13(5): 703-7.10.1111/j.1440-1843.2008.01327.x
  16. 16. HOWES TQ, DEANE CR, LEVIN GE, BAUDOUIN SV, MOXHAM J. The effects of oxygen and dopamine on renal and aortic blood flow in chronic obstructive pulmonary disease with hypoxemia and hypercapnia. Am J Resp Crit Care Med 1995; 151(2): 378-383.10.1164/ajrccm.151.2.7842195
  17. 17. RICH R. Principle of immune reactions. In: Rich R, Fleisher T. Clinical immunology. Huston: Mosby; 1995: 317-330.
  18. 18. SKWARSKI KM, MARRISON D, BARRATT A, LEE M, MACNEEW. Effect of hypoxemia on renal hormonal balance in normal subject and in patients with COPD. Respir Med 1998; 92(12):1331-6.10.1016/S0954-6111(98)90138-X
  19. 19. OLAFSDOTTIR IS, GISLASON T, THJODLEIFSSON B, OLAFSSON I, GÍSLASON D, JÕGI R et al. Gender differences in the association between C-reactive protein, Lung function impairment, and COPD. Int J Chron Obstract Pulmon Dis. 2007; 2(4): 635-42
  20. 20. ANAND IS, CHANDRASHEKHAR Y, FERRARI R, SARMA R, GULERIA R, JINDAL SK et al. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation 1992; 86 (1):12–21.10.1161/01.CIR.86.1.12
  21. 21. SIN DD, MAN SF. Is systemic inflammation responsible for pulmonary hypertension in COPD? Chest 2006; 130 (2): 310-12.
  22. 22. MANNIX ET, DOWDESWELL IRG, CARLONE S, PALANGE P, ARONOFF GR, FARBER MO. The effect of oxygen on sodium excretion in hypoxemic patients with chronic obstructive lung disease. Chest 1990; 97 (4): 840-4.10.1378/chest.97.4.840
  23. 23. CAMPBELL EJM, SHORT DS. The cause of edema in “corpulmonale” Lancet 1960; I: 1184-6.10.1016/S0140-6736(60)91062-X
  24. 24. REINECK HJ, STEIN JH. Sodium metabolism. In: Maxwell MH, Kleeman CR, Narins RG, eds. Clinical disorders of fluid and electrolyte metabolism. New York: McGraw-Hill, 1987: 39-40.
  25. 25. BATHOORN E, KERSTJENS H, POSTMA D, TIMENS W, MACNEE W. Airways inflammation and treatment during acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis 2008; 3(2): 217-29.10.2147/COPD.S1210262996118686731
DOI: https://doi.org/10.1515/rjim-2015-0044 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 343 - 347
Submitted on: Jun 30, 2014
Published on: Dec 10, 2015
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Fariba Rezaeetalab, Abbas Ali Zeraatti, Farzaneh Sharifipour, Rozita Davoodi, Hoorak Pourzand, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.